This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Otsuka Pharmaceutical Factory, Inc.. Active years: 1990-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1992
Title: Kayoko Shinomiya: Innovator in Pharmaceutical Composition for Hyperlipidemia
Introduction
Kayoko Shinomiya is a prominent inventor based in Tokushima, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hyperlipidemia. With a total of 2 patents, her work focuses on innovative methods and compositions that address lipid-related health issues.
Latest Patents
One of her latest patents is a method for treating hyperlipidemia, which involves a pharmaceutical composition containing carboxamide compounds. These compounds are represented by a specific formula and are known for their excellent activities in lowering serum lipid levels. Importantly, they exhibit low toxicity and high safety, making them suitable for therapeutic use. The pharmacological activities of these carboxamide compounds for treating hyperlipidemia had not been previously identified, highlighting the novelty of her work. Additionally, she has developed novel carboxamide compounds that are effective in treating and preventing various lipid-related diseases, including hypercholesterolemia and hypertriglyceridemia.
Career Highlights
Throughout her career, Kayoko Shinomiya has worked with notable organizations, including Otsuka Pharmaceutical Factory, Inc. Her experience in the pharmaceutical industry has equipped her with the knowledge and skills necessary to innovate in the field of lipid management.
Collaborations
She has collaborated with esteemed colleagues such as Kazuhiko Tsutsumi and Eiji Uesaka, contributing to the advancement of research and development in her area of expertise.
Conclusion
Kayoko Shinomiya's contributions to the pharmaceutical industry, particularly in the treatment of hyperlipidemia, demonstrate her commitment to innovation and health improvement. Her work continues to pave the way for new therapeutic options in managing lipid-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
